doi: 10.1161/CIRCULATIONAHA.105.548727
(Circulation. 2006;113:405-413.)
© 2006 American Heart Association, Inc.
Imaging |
Ventricular Fibrosis Suggested by Cardiovascular Magnetic Resonance in Adults With Repaired Tetralogy of Fallot and Its Relationship to Adverse Markers of Clinical Outcome
From the Adult Congenital Heart Unit (S.V.B.-N., W.L., O.G., P.A.D., M.A.G.) and the Cardiovascular Magnetic Resonance Unit (S.V.B.-N., P.J.K., J.C.M., D.J.P.), Royal Brompton Hospital, London, United Kingdom; and the National Heart and Lung Institute (S.V.B.-N., P.J.K., W.L., M.K., S.Y.H., D.J.P., M.A.G.), Imperial College, London, United Kingdom.
Correspondence to Dr Sonya V. Babu-Narayan, Adult Congenital Heart Unit, Royal Brompton Hospital, Sydney St, London SW3 6NP, United Kingdom. E-mail sonya{at}doctors.org.uk
Received March 11, 2005; revision received October 28, 2005; accepted November 21, 2005.
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Background— Late morbidity and mortality remain problematic after repair of tetralogy of Fallot (TOF). We hypothesized that fibrosis detected by late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) would be present in adults with repaired TOF and would be related to adverse markers of outcome.
Method and Results— LGE was scored in the right and left ventricles (RV and LV) of 92 adult patients who had undergone TOF repair. RV LGE was seen in all patients at surgical sites located in the outflow tract (99%) or the site of ventricular septal defect patching (98%) and in the inferior RV insertion point (79%) and trabeculated myocardium (24%). LV LGE (53%) was located at the apex consistent with apical vent insertion (49%), in the inferior or lateral wall consistent with infarction (5%), or in other areas (8%). Patients with supramedian RV LGE score were older (38 versus 27 years, P<0.001) and more symptomatic (38% versus 8% in New York Heart Association class II or greater, P=0.001), had increased levels of atrial natriuretic peptide (7.3 versus 4.9 pmol/L, P=0.041), and had a trend to higher brain natriuretic peptide (12.3 versus 7.2 pmol/L, P=0.086), exercise intolerance (maximum 
O2 24 versus 28 mL · min–1 · kg–1, P=0.021), RV dysfunction (RV end-systolic volume 61 versus 55 mL/m2, P=0.018; RV ejection fraction 50% versus 56%, P=0.007), and clinical arrhythmia (26% versus 10%, P=0.039). Non–apical vent LV LGE also correlated with markers of adverse outcome. In a multivariate model, RV LGE remained a predictor of arrhythmia.
Conclusions— RV and LV LGE were common after TOF repair and were related to adverse clinical markers, including ventricular dysfunction, exercise intolerance, and neurohormonal activation. Furthermore, RV LGE was significantly associated with clinical arrhythmia.
Key Words: arrhythmia • magnetic resonance imaging • risk factors • tetralogy of Fallot • fibrosis
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Advances in cardiothoracic surgery have greatly improved the prognosis for patients who undergo repair of tetralogy of Fallot (TOF); however, late ventricular dysfunction remains a problem and is related to pulmonary regurgitation, arrhythmia, and sudden cardiac death.1–4 Autopsy specimens have suggested fibrosis to be causative.5 Late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) has already contributed to our understanding of the pathophysiology of both ischemic6–8 and nonischemic9–11 causes of dysfunction in the left ventricle (LV) and has been validated with histology in these contexts. LGE suggestive of fibrosis has also been demonstrated in the systemic right ventricle.12 In the present study, we hypothesized that LGE would be present in adults with surgically repaired TOF and that it would relate to ventricular dysfunction and potentially to markers of clinical outcome.
Clinical Perspective p 413
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Patient Population
Consecutive patients from a dedicated adult congenital heart clinic who had undergone repair of TOF between August 2002 and January 2005 participated. Patients with a permanent pacemaker were excluded. The study was approved by the local research ethics committee, and all patients gave written informed consent. Ninety-two patients (56 males) were studied with LGE CMR. One further patient attended, but the study was excluded owing to a mild, self-limiting reaction to contrast.
CMR Acquisition and Regional Assessment
All scans were acquired with a 1.5-T scanner (Siemens Sonata). After routine assessment of anatomy, a short-axis contiguous stack of steady-state free-precession cine images (7-mm slices) from the atrioventricular ring to the apex was acquired. All patients underwent a standardized full assessment, including quantification of the degree of pulmonary regurgitation by non–breath-hold phase-velocity mapping in a plane transecting the reconstructed pulmonary trunk13 and measurement of biventricular volumes and function. Both the right ventricle (RV) and LV were also imaged in at least 3 long-axis and the short-axis planes. The maximum linear extent of the akinetic area identified in 1 or more of these planes was measured by 2 observers (PJK and SVB).
CMR Analysis of Volumes and Mass
All scans were rendered anonymous. The short-axis stack was quantified by planimetry by Simpson’s method to determine myocardial mass and ventricular function with semiautomated software (CMRtools, Cardiovascular Imaging Solutions). A single observer (SVB) made all measurements. The RV free wall below the pulmonary valve and trabecular ridges and bands on the RV side of the septum were included in RV mass and excluded from blood pool measurements. The reproducibility for this population has been described previously.14 The following measurements were included: RV and LV end-diastolic volume index (EDVi); RV and LV end-systolic volume index (ESVi); RV and LV ejection fraction (EF); RV and LV mass index.
CMR LGE Acquisition
Late gadolinium imaging was performed as described previously 12 by a single operator (SVB) with the use of a 2D segmented fast low-angle shot inversion recovery sequence, with the acquisition optimized for imaging nonischemic myocardial fibrosis and the RV.12 Briefly, imaging was performed from 5 minutes after injection of gadolinium-DTPA 0.1 mmol/kg IV. Great care was taken to exclude or recognize artifacts during acquisition, including off-null effects. The inversion time was adjusted meticulously to maintain nulling of healthy myocardium, typically increasing from 310 to 420 ms. Imaging parameters were optimized to individual patient heart rate and breath-hold ability, and scanning proceeded quickly, typically with 30 views taken in less than 10 minutes, with phase swapping, systolic images, and crosscuts to define sometimes subtle RV LGE. Both ventricles were covered by imaging all short-axis views from base to apex with inversion recovery after gadolinium. In addition, standard LV long-axis planes, RV long-axis planes including a sagittal RV outflow tract, RV outflow tract (RVOT), and RV oblique and 4-chamber views, as well as crosscuts of suspected enhanced regions, were acquired. Any crosscuts were also compared with a further cine image acquired in the corresponding plane.
LGE Analysis
For the LV, a standard 17-segment model was used, with segments scored on a 5-point scale (0=no LGE and 1=1% to 24%, 2=25% to 49%, 3=50% to 74%, and 4=75% to 100% of the myocardium in the segment that showed LGE).15 For the RV, segments have been described,16 but no universally accepted segmentation system exists, particularly with respect to the heart after repair of TOF. Therefore, we designed a segmentation system to account for the anatomy and geometry of the RV after repair of TOF and the types of LGE found (Figure 1). LGE was considered present if there was bright signal within the myocardium (not blood pool), in good-quality late enhancement images in locations that either did not alter when reimaged in the same plane with a phase swap or that were also visible in another plane that cut the area in question. Locations were not double-counted. The maximum score was 20. We confirmed the interstudy reproducibility of this semiquantitative scoring system by repeating scans and analysis on 20 patients (mean 6-month interval) blind to the previous study (SVB, PJK).
|
Other Investigations
Standard 12-lead ECGs were acquired for all patients. QRS duration, QTc, and QT and JT dispersions were measured manually (OG).17,18 RV restrictive physiology was assessed by a single echocardiographer (WL) looking for laminar anterograde flow in the pulmonary artery in late diastole present throughout the respiratory cycle (the a wave).19,20 Echocardiographic data were available for 81 of 92 patients. Venous blood was taken from 70 patients after 20 minutes of supine rest and immediately centrifuged at 3000 rpm for 15 minutes at 4°C. Aprotinin plasma aliquots were stored at –75°C until subsequent batch analysis (immunoradiometric assay) for A- and B-type natriuretic peptides (ANP and BNP). Cardiopulmonary exercise testing was performed with graded treadmill exercise. After we obtained resting measurements, all patients were encouraged to exercise to exhaustion. Resting and peak heart rate and blood pressure, duration of exercise, maximum O2, O2 expressed as a percentage of predicted, E/CO2 slope, anaerobic threshold, and R value were recorded. Maximum O2, E/CO2, and anaerobic threshold were excluded from analysis if the R value was <1 (n=7). Clinical arrhythmia was defined as sustained arrhythmia associated with symptoms or syncope with ECG confirmation. Arrhythmia included both atrial and ventricular arrhythmias but not nonsustained Holter ventricular tachycardia.4,21
Statistical Analysis
All continuous variables were expressed as mean±SD or median (quartile 1–quartile 3) according to distribution. Continuous variables were analyzed by either 2-sample independent t test or Mann-Whitney test where appropriate. Correlations were assessed by Spearman rank correlation coefficient. Categorical data were analyzed by 
2 test. A nonparametric Kruskal-Wallis test was used to compare different variables in the lower, middle, and upper quartiles of RV LGE score. A binary logistic regression model was constructed to test whether RV LGE was statistically a "predictor" of clinical arrhythmia after adjustment for age and exercise duration. Intraclass correlation coefficient was used to assess reproducibility of the RV LGE score. A probability value less than 0.05 was considered statistically significant. All data were analyzed with SPSS version 11 (SPSS Inc).
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Patient Demographics
Patient characteristics are summarized in Table 1.
|
RV LGE: Locations and Types
All patients had RV LGE; 3 basic types were observed. First, RV LGE occurred at surgical sites in all patients in the RVOT (99%) and/or the site of ventricular septal defect patching (98%;Figure 2). Second, RV LGE occurred in the RV trabeculations including the moderator band (22/92, or 24%; Figure 3); these patients were older, had later repair, and had higher RV ESVi (age 36.9±10 versus 30.6±11 years; repair at 6.0 [4.5 to 13.0] versus 4.0 [2.0 to 8.0] years; and ESVi 61.2 (52.6 to 84.3) versus 54.4 (41.4 to 71.1) mL/m2; P=0.025, 0.034, and 0.046, respectively). Third, RV LGE occurred frequently at the RV insertion points (inferior 74/92, or 79%; superior 13/92, or 14%; Figure 2). No significant clinical or functional correlates were found with this pattern, so RV insertion point enhancement was excluded from all subsequent analysis.
|
|
RV LGE: Clinical Correlates
The extent of RV LGE varied widely (mean score 4.0±2.4, median 3; interquartile range 3 to 5; Figures 2 and 3
). The group of patients with above-median scores was older and had longer follow-up, later repair, and adverse clinical markers, including decreased exercise tolerance, increased neurohormones, increased RV ESVi, decreased RV EF, higher LV LGE scores, and more documented clinical arrhythmia (Table 2), but there were no significant ECG differences between the 2 groups. Patients were divided into lower-quartile, middle-quartiles, and upper-quartile RV LGE groups. Age, age at repair, longer follow-up, ANP, BNP, RV ESVi, and LV LGE were significantly different in different RV LGE groups (Kruskall-Wallis P<0.05; Figure 4). Patients with extensive RV LGE (
75th centile; n=23) were more likely to have restrictive RV physiology (11/23 [43%] versus 12/58 [24%], P=0.037).
|
|
LV LGE: Locations and Types
Three basic types of LV LGE were observed. First, LV LGE occurred at the apex, segment 17 (42/87; 48%), consistent with insertion of an apical vent at surgery (Figure 2). This did not correlate with any adverse markers apart from age (34±9.3 versus 28±12 years, P<0.001). Second, LV LGE typical of myocardial infarction was found in 5 (5%) of 92 cases (Figure 5). This was located inferiorly or laterally in all cases and also involved the apex, but a greater extent of LGE distinguished these cases from the first group. Third, discrete foci of LV LGE occurred in other locations in 7 patients. In 3 of these patients, noncontrast imaging showed that the LGE was associated with focal myocardial fatty infiltration.
|
LV LGE: Clinical Correlates
Total LV LGE score correlated weakly with RV LGE score (r=0.39, P<0.001). Patients with LV LGE not consistent with an apical vent (non–apical vent LV LGE) had higher RV LGE score (4.0 [4.0 to 7.0] versus 3.0 [2.0 to 5.0], P=0.004) and more arrhythmia (5/16 versus 7/76, P=0.017) and were older (39±11 versus 31±11 years, P=0.018), with later repair (8.0 [4.0 to 34.0] versus 4.0 [2.0 to 7.0] years, P=0.017), although there was no difference in the length of follow-up (33 [15–34] versus 26 [18–32] years, P=NS). They had lower peak heart rate and shorter exercise duration (162 [126–171] versus 173 [162–190] bpm, 558 [459–775] versus 824 [658–920] s, P=0.006 and 0.025, respectively) and higher ANP (10.4 [7.4 to 16.8] versus 5.3 [3.2 to 7.8) pmol/L, P=0.009). LV volume was increased (LV EDVi 83.9 [76.8 to 88.6] versus 68.7 [60.8 to 80.8] and LV ESVi 40±20 versus 25±11 mL/m2, P=0.012 and 0.017, respectively), and LV EF decreased (55±14% versus 66±7%, P=0.027). Similarly, the LV infarction patients (n=5) were older, with later repair (age 45±6 versus 32±11, repair at 11±3 versus 7±6 years; P=0.007 and 0.015, respectively) but also had a greater incidence of previous palliative shunt (4/5 versus 27/87, P=0.04), more redo surgery to the pulmonary valve (4/5 versus 17/87, P=0.009), and increased BNP (30.4±16.5 versus 10.3±7.5 pmol/L, P=0.021).
LGE and Arrhythmia
Patients with documented clinical arrhythmia were older and had a more frequent history of redo surgery, reduced exercise capacity, more symptoms, and more RV and LV LGE (Table 3). By multivariate analysis with the 3 most clinically relevant variables (age, exercise duration, and RV LGE score), RV LGE score remained a predictor of arrhythmia, despite adjustment for both age and exercise duration. Exercise duration also remained an inverse predictor, but age did not. Each unit increase in RV LGE score was associated with a 34% greater likelihood of documented clinical arrhythmia (OR 1.34, 95% CI 1.04 to 1.81; P=0.032).
|
Interscan LGE Reproducibility
LGE CMR applied to the RV with this scoring system was highly reproducible (intraclass correlation coefficient 0.97 for RV and 1.0 for LV). The high LV reproducibility was driven by the clear presence or absence of evidence of transmural apical vents.
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Myocardial LGE was present in both the RV and LV of adults with repaired TOF and was related to increased age, impaired exercise capacity, ventricular dysfunction, and clinical arrhythmia. LGE has become widely regarded as a marker of fibrosed, scarred, or otherwise abnormal myocardium, an assumption that has been validated histologically in selected cases.10,22 In this setting, we believe that LGE represents fibrosis, in agreement with a previous histological study.5
Surgical Scarring, Akinetic RVOT Areas, and RV LGE
LGE was commonly seen in locations that probably reflected surgical resection, incision, patching, suturing, or vent insertion. All patients had RV LGE in the RVOT free wall, whether or not a patch had been used. Thin, akinetic, sometimes bulging RVOT regions are a frequent finding in patients with repaired TOF, and they have a negative impact on EF23 and provide a substrate for arrhythmia.24 The RVOT LGE generally correlated with RVOT wall-motion abnormality, but in some cases, LGE indicated the presence of fibrosis in areas that cannot be detected by cine images alone (for example, in trabeculated and endomyocardial regions).
RV Fibrosis: Early Insult, Perioperative Damage, or Progressive Change?
RV LGE likely reflects previous myocardial insult. Patients with more fibrosis had later repair, which suggests that preoperative cyanosis and pressure overload may have predisposed to myocardial damage. In older TOF patients, fibrosis may also reflect an earlier surgical era of repair via ventriculotomy and perhaps more aggressive RVOT reconstruction, with more transannular patch use. Unintended perioperative adverse effects, such as damage to the right coronary artery or its branches or the negative effect of cardiopulmonary bypass, could also play a role. Younger patients, in contrast, may have benefited from improvements in surgical and bypass techniques, including myocardial protection, and so have lower fibrosis scores despite having LGE in similar locations. LGE was also seen in sites remote from surgical instrumentation, in trabecular and endocardial sites, which may be more vulnerable to ischemic insult. Such patients had decreased RV function, increased age, and later repair, with a trend to longer follow-up since surgery, but whether the ischemic insult was preoperative, perioperative, or postoperative remains unknown. We postulate that at least 1 of the mechanisms for progressive fibrosis is ventricular dilatation and hypertrophy resulting from pulmonary regurgitation or stenosis, which leads to stretching, arrhythmia generation, and adverse RV remodeling, particularly in vulnerable border zones between normal and fibrotic myocardium.
LV Fibrosis
LV LGE relating to apical vent insertion was expected,25 but other locations require further explanation. Small, localized, discrete LV LGE may be due to perioperative, embolic microinfarction. Indeed, 5 patients had a pattern consistent with infarction and wall-motion abnormalities. Potential mechanisms include perioperative damage to anomalous or normal coronary arteries; adverse, progressive ventricular-ventricular interaction23; and silent myocardial infarction due to acquired ischemic heart disease. LV dysfunction is known to relate to adverse outcomes,26,27 and our findings lend support to fibrosis as a potentially relevant cause.
Clinical Relevance
The extent of RV fibrosis was related not only to adverse markers of RV systolic function, particularly RV ESVi and RV EF, but also to restrictive physiology, neurohormonal activation, and exercise intolerance, which supports the clinical relevance of the RV LGE seen in the present study. The burden of pulmonary regurgitation was substantial in the present study cohort. Pulmonary valve replacement is reported to be beneficial,28 although optimal timing is unclear. Assessment of RV LGE may contribute to this challenging decision-making process. In multivariate analysis, RV LGE score was a predictor of documented clinical arrhythmia, despite adjustment for age and exercise duration. Islands of fibrosis represent potential foci of ventricular reentry. Arrhythmia documented in patients in the present study included sustained ventricular tachycardia and syncope but also atrial tachycardia, which was more common. In patients with evidence of extensive RV (and LV) fibrosis, the latter may be a marker of ventricular dysfunction.29,30 RV LGE and its extent may therefore contribute to risk stratification for arrhythmia and sudden cardiac death and thus assist in decision making with regard to arrhythmia intervention, including automated internal cardiac defibrillator implantation.
Study Limitations
In this evaluation of RV LGE patterns in TOF, we have grouped different patterns and assumed that they related to fibrosis, although no histological validation has been performed. In the longer term, documentation of in vivo changes and correlation with postmortem histological appearances may be possible. The cross-sectional nature of this study limits its ability to determine the precise mechanisms or rate of progression of fibrosis, because cause-and-effect cannot be disentangled. In terms of multivariate analysis, this is a population with relatively few clinical events to predict; however, only 3 variables were put into the multivariate model, and therefore, in our opinion, the data have not been overfitted. A larger, prospectively followed-up cohort may give further information on additional causes of fibrosis, its precise prognostic value, and its potential response to different interventions.
Conclusions
RV and LV LGE suggestive of fibrosis are common after TOF repair. The findings described here give new in vivo insights into late pathophysiological mechanisms. The presence of fibrosis was related to adverse clinical markers, including ventricular dysfunction, exercise intolerance, and neurohormonal activation. In particular, RV LGE was a predictor of arrhythmia, which has potential prognostic implications with respect to morbidity and mortality. Further studies may validate the role of LGE CMR in risk stratification and optimal timing of hemodynamic surgery or arrhythmia intervention.
|
Acknowledgments |
|---|
Dr Babu-Narayan was supported by the British Heart Foundation. The Cardiovascular Magnetic Resonance Unit was supported by the British Heart Foundation, CORDA, and Siemens. We are grateful for the support received from adult congenital heart disease patients and staff at the Royal Brompton Hospital.
Disclosure
None.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Murphy JG, Gersh BJ, Mair DD, Fuster V, McGoon MD, Ilstrup DM, McGoon DC, Kirklin JW, Danielson GK. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med. 1993; 329: 593–599.
2. Nollert G, Fischlein T, Bouterwek S, Bohmer C, Klinner W, Reichart B. Long-term survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair. J Am Coll Cardiol. 1997; 30: 1374–1383.[Abstract]
3. Therrien J, Siu SC, Harris L, Dore A, Niwa K, Janousek J, Williams WG, Webb G, Gatzoulis MA. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation. 2001; 103: 2489–2494.
4. Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, Rosenthal M, Nakazawa M, Moller JH, Gillette PC, Webb GD, Redington AN. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000; 356: 975–981.[CrossRef][Medline] [Order article via Infotrieve]
5. Deanfield JE, Ho SY, Anderson RH, McKenna WJ, Allwork SP, Hallidie-Smith KA. Late sudden death after repair of tetralogy of Fallot: a clinicopathologic study. Circulation. 1983; 67: 626–631.
6. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, Judd RM. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001; 218: 215–223.
7. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000; 343: 1445–1453.
8. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet. 2001; 357: 21–28.[CrossRef][Medline] [Order article via Infotrieve]
9. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, Pennell DJ. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003; 108: 54–59.
10. Moon JC, Reed E, Sheppard MN, Elkington AG, Ho SY, Burke M, Petrou M, Pennell DJ. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004; 43: 2260–2264.
11. Choudhury L, Mahrholdt H, Wagner A, Choi KM, Elliott MD, Klocke FJ, Bonow RO, Judd RM, Kim RJ. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002; 40: 2156–2164.
12. Babu-Narayan SV, Goktekin O, Moon JC, Broberg CS, Pantely G, Pennell DJ, Gatzoulis MA, Kilner PJ. Late gadolinium enhancement cardiovascular magnetic resonance of the systemic right ventricle in adults with previous atrial redirection surgery for transposition of the great arteries. Circulation. 2005; 26: 111:2091–2098.
13. Rebergen SA, Chin JG, Ottenkamp J, van der Wall EE, de Roos A. Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot: volumetric quantitation by nuclear magnetic resonance velocity mapping. Circulation. 1993; 88: 2257–2266.
14. Babu-Narayan SV, Bouzas B, Broberg CS, Kilner PJ. Interstudy reproducibility of right and left ventricular volume and mass measurements by cardiovascular magnetic resonance in repaired tetralogy of Fallot patients. J Cardiovasc Magn Reson. 2005; 7: 153.
15. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS, American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002; 105: 539–542.
16. Klein SS, Graham TP Jr, Lorenz CH. Noninvasive delineation of normal right ventricular contractile motion with magnetic resonance imaging myocardial tagging. Ann Biomed Eng. 1998; 26: 756–763.[CrossRef][Medline] [Order article via Infotrieve]
17. Gatzoulis MA, Till JA, Somerville J, Redington AN. Mechanoelectrical interaction in tetralogy of Fallot: QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. 1995; 92: 231–237.
18. Gatzoulis MA, Till JA, Redington AN. Depolarization-repolarization inhomogeneity after repair of tetralogy of Fallot: the substrate for malignant ventricular tachycardia? Circulation. 1997; 95: 401–404.
19. Gatzoulis MA, Clark AL, Cullen S, Newman CG, Redington AN. Right ventricular diastolic function 15 to 35 years after repair of tetralogy of Fallot: restrictive physiology predicts superior exercise performance. Circulation. 1995; 91: 1775–1781.
20. Norgård G, Gatzoulis MA, Moraes F, Lincoln C, Shore DF, Shinebourne EA, Redington AN. Relationship between type of outflow tract repair and postoperative right ventricular diastolic physiology in tetralogy of Fallot: implications for long-term outcome. Circulation. 1996; 94: 3276–3280.
21. Cullen S, Celermajer DS, Franklin RC, Hallidie-Smith KA, Deanfield JE. Prognostic significance of ventricular arrhythmia after repair of tetralogy of Fallot: a 12-year prospective study. J Am Coll Cardiol. 1994; 23: 1151–1155.[Abstract]
22. Maceira AM, Joshi J, Prasad SK, Moon JC, Perugini E, Harding I, Sheppard MN, Poole-Wilson PA, Hawkins PN, Pennell DJ. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005; 111: 186–193.
23. Davlouros PA, Kilner PJ, Hornung TS, Li W, Francis JM, Moon JC, Smith GC, Tat T, Pennell DJ, Gatzoulis MA. Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular magnetic resonance imaging: detrimental role of right ventricular outflow aneurysms or akinesia and adverse right-to-left ventricular interaction. J Am Coll Cardiol. 2002; 40: 2044–2052.
24. Downar E, Harris L, Kimber S, Mickleborough L, Williams W, Sevaptsidis E, Masse S, Chen TC, Chan A, Genga A, Glanz A. Ventricular tachycardia after surgical repair of tetralogy of Fallot: results of intraoperative mapping studies. J Am Coll Cardiol. 1992; 20: 648–655.[Abstract]
25. Moon JC, Sievers B, Pennell DJ, Yacoub MH, Mohiaddin RH. Myocardial scarring caused by left ventricular assist device (LVAD) insertion demonstrated by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2003; 5: 361–363.[Medline] [Order article via Infotrieve]
26. Ghai A, Silversides C, Harris L, Webb GD, Siu SC, Therrien J. Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot. J Am Coll Cardiol. 2002; 40: 1675–1680.
27. Geva T, Sandweiss BM, Gauvreau K, Lock JE, Powell AJ. Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging. J Am Coll Cardiol. 2004; 43: 1068–1074.
28. Vliegen HW, van Straten A, de Roos A, Roest AA, Schoof PH, Zwinderman AH, Ottenkamp J, van der Wall EE, Hazekamp MG. Magnetic resonance imaging to assess the hemodynamic effects of pulmonary valve replacement in adults late after repair of tetralogy of Fallot. Circulation. 2002; 106: 1703–1707.
29. Gatzoulis MA, Walters J, McLaughlin PR, Merchant N, Webb GD, Liu P. Late arrhythmia in adults with the Mustard procedure for transposition of great arteries: a surrogate marker for right ventricular dysfunction? Heart. 2000; 84: 409–415.
30. Harrison DA, Siu SC, Hussain F, MacLoghlin CJ, Webb GD, Harris L. Sustained atrial arrhythmias in adults late after repair of tetralogy of Fallot. Am J Cardiol. 2001; 87: 584–588.[CrossRef][Medline] [Order article via Infotrieve]
 |
|
 |
|
  D. J. Pennell Cardiovascular Magnetic Resonance Circulation, February 9, 2010; 121(5): 692 - 705. [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Kilner, T. Geva, H. Kaemmerer, P. T. Trindade, J. Schwitter, and G. D. Webb Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European Society of Cardiology Eur. Heart J., January 11, 2010; (2010) ehp586v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Sugimoto, S Masutani, M Seki, H Kajino, K Fujieda, and H Senzaki High serum levels of procollagen type III N-terminal amino peptide in patients with congenital heart disease Heart, December 15, 2009; 95(24): 2023 - 2028. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. W.K. Peng, S. Lilley, B. Knight, J. Sinclair, F. Lyall, K. MacArthur, J. C.S. Pollock, and M. H.D. Danton Synergistic interaction between right ventricular mechanical dyssynchrony and pulmonary regurgitation determines early outcome following tetralogy of Fallot repair Eur. J. Cardiothorac. Surg., October 1, 2009; 36(4): 694 - 702. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F P JUNQUEIRA, R MACEDO, A C COUTINHO, R LOUREIRO, P V DE PONTES, R C DOMINGUES, and E L GASPARETTO Myocardial delayed enhancement in patients with pulmonary hypertension and right ventricular failure: evaluation by cardiac MRI Br. J. Radiol., October 1, 2009; 82(982): 821 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hoashi, G. Matsumiya, S. Miyagawa, H. Ichikawa, T. Ueno, M. Ono, A. Saito, T. Shimizu, T. Okano, N. Kawaguchi, et al. Skeletal myoblast sheet transplantation improves the diastolic function of a pressure-overloaded right heart. J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 460 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Friedberg and L. Mertens Tissue velocities, strain, and strain rate for echocardiographic assessment of ventricular function in congenital heart disease Eur J Echocardiogr, July 1, 2009; 10(5): 585 - 593. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Flett, M. A. Westwood, L. C. Davies, A. Mathur, and J. C. Moon The Prognostic Implications of Cardiovascular Magnetic Resonance Circ Cardiovasc Imaging, May 1, 2009; 2(3): 243 - 250. [Full Text] [PDF]
|
|
|
|
|
|
R. M. Wald, I. Haber, R. Wald, A. M. Valente, A. J. Powell, and T. Geva Effects of Regional Dysfunction and Late Gadolinium Enhancement on Global Right Ventricular Function and Exercise Capacity in Patients With Repaired Tetralogy of Fallot Circulation, March 17, 2009; 119(10): 1370 - 1377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. V Huehnergarth, M. Gurvitz, K. K Stout, and C. M Otto Repaired tetralogy of Fallot in the adult: monitoring and management Heart, December 1, 2008; 94(12): 1663 - 1669. [Full Text] [PDF]
|
|
|
|
|
|
A. Frigiola, V. Tsang, C. Bull, L. Coats, S. Khambadkone, G. Derrick, B. Mist, F. Walker, C. van Doorn, P. Bonhoeffer, et al. Biventricular Response After Pulmonary Valve Replacement for Right Ventricular Outflow Tract Dysfunction: Is Age a Predictor of Outcome? Circulation, September 30, 2008; 118(14_suppl_1): S182 - S190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Witte, C. B. Pepper, J. C. Cowan, J. D. Thomson, K. M. English, and M. E. Blackburn Implantable cardioverter-defibrillator therapy in adult patients with tetralogy of Fallot Europace, August 1, 2008; 10(8): 926 - 930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bordachar, X. Iriart, J. Chabaneix, F. Sacher, S. Lafitte, P. Jais, M. Haissaguerre, J. Clementy, P. Dos Santos, and J.-B. Thambo Presence of ventricular dyssynchrony and haemodynamic impact of right ventricular pacing in adults with repaired Tetralogy of Fallot and right bundle branch block Europace, August 1, 2008; 10(8): 967 - 971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Crean Cardiovascular MR and CT in congenital heart disease Heart, December 1, 2007; 93(12): 1637 - 1647. [Full Text] [PDF]
|
|
|
|
 |
|
 G.-P. Diller, K. Dimopoulos, H. Kafka, S. Y. Ho, and M. A. Gatzoulis Model of chronic adaptation: right ventricular function in Eisenmenger syndrome Eur. Heart J. Suppl., December 1, 2007; 9(suppl_H): H54 - H60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-Y. Lam, M. G. Kaya, O. Goktekin, M. A. Gatzoulis, W. Li, and M. Y. Henein Restrictive Right Ventricular Physiology: Its Presence and Symptomatic Contribution in Patients With Pulmonary Valvular Stenosis J. Am. Coll. Cardiol., October 9, 2007; 50(15): 1491 - 1497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Uebing, D. G. Gibson, S. V. Babu-Narayan, G. P. Diller, K. Dimopoulos, O. Goktekin, M. S. Spence, K. Andersen, M. Y. Henein, M. A. Gatzoulis, et al. Right Ventricular Mechanics and QRS Duration in Patients With Repaired Tetralogy of Fallot: Implications of Infundibular Disease Circulation, October 2, 2007; 116(14): 1532 - 1539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. R. Henkens, A. van Straten, M. J. Schalij, M. G. Hazekamp, A. de Roos, E. E. van der Wall, and H. W. Vliegen Predicting Outcome of Pulmonary Valve Replacement in Adult Tetralogy of Fallot Patients Ann. Thorac. Surg., March 1, 2007; 83(3): 907 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Harris, T. R. Johnson, P. M. Weinberg, and M. A. Fogel Delayed-enhancement cardiovascular magnetic resonance identifies fibrous tissue in children after surgery for congenital heart disease J. Thorac. Cardiovasc. Surg., March 1, 2007; 133(3): 676 - 681. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. McCann, C. T. Gan, A. M. Beek, H. W. M. Niessen, A. V. Noordegraaf, and A. C. van Rossum Extent of MRI Delayed Enhancement of Myocardial Mass Is Related to Right Ventricular Dysfunction in Pulmonary Artery Hypertension Am. J. Roentgenol., February 1, 2007; 188(2): 349 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ooi, N. Moorjani, G. Baliulis, B. R. Keeton, A. P. Salmon, J. L. Monro, and M. P. Haw Medium term outcome for infant repair in tetralogy of Fallot: indicators for timing of surgery Eur. J. Cardiothorac. Surg., December 1, 2006; 30(6): 917 - 922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A Shinebourne, S. V Babu-Narayan, and J. S Carvalho Tetralogy of Fallot: from fetus to adult. Heart, September 1, 2006; 92(9): 1353 - 1359. [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||